+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hepatorenal Syndrome Treatment Market: By Treatment - Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

  • PDF Icon

    Report

  • 130 Pages
  • December 2019
  • Region: Global
  • Zion Market Research
  • ID: 5143175
Description Jump to:
The report covers forecast and analysis for the Hepatorenal Syndrome Treatment market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the Hepatorenal Syndrome Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Hepatorenal Syndrome Treatment market on a global level. In order to give the users of this report a comprehensive view on the Hepatorenal Syndrome Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Treatment, End users, Type, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

According to the report, global demand for Hepatorenal Syndrome Treatment Market was valued at approximately USD 10.83 Billion in 2018, and is expected to generate revenue of around USD 15.65 Billion by end of 2025, growing at a CAGR of around 5.45% between 2018 and 2025.

In patients with chronic liver disease or liver cirrhosis, hepatorenal syndrome or HRS is a medical condition characterized by progressive renal failure. Cirrhosis is a life-threatening and severe complication. Patients with HRS usually do not have any identifiable cause of kidney dysfunction as they are not structurally impaired by the kidneys themselves. It can be called kidney impairment as a "functional" form. Patients with hepatorenal syndrome usually have a number of symptoms, such as abdominal pain, fatigue, and discomfort. Those who are severely affected also have symptoms such as jaundice-like yellowing of the skin and eye whites, highly swollen liver and spleen, and fluid accumulation in the abdomen called ascites.

The study provides a decisive view on the Hepatorenal Syndrome Treatment market by segmenting the market based on Treatment, End users, Type, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Treatment, the market is segmented into Therapeutics and surgical treatment. Therapeutics segment is projected to rise in the market for treatment of hepatorenal syndrome. Therefore, lucrative prospects are attracting the attention of healthcare companies in the clinical landscape.

Based on the End users, the market is bifurcated Hospitals and Clinics, Ambulatory Surgical centers, Academic Research Institutes, and others. Hospitals segment is projected to be the largest segment under the end user segment in the hepatorenal syndrome treatment market. Based on the Type segment, the market is bifurcated into Type 1 Hepatorenal Syndrome and Type 2 Hepatorenal Syndrome.

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. For 2018, the major regional markets for hepatorenal syndrome care are North America, Europe, and Asia Pacific. During the forecast period, the markets for treatment of hepatorenal syndrome for North America and Asia Pacific are likely to expand.

Increased awareness of disease and patient support programs to boost the market for treatment of Hepatorenal syndrome. Governments in developed and developing countries conduct awareness campaigns to encourage people to go for early diagnosis of kidney and liver disease in order to reduce mortality and morbidity levels. It, in effect, is expected to increase understanding of the diagnosis and treatment of Hepatorenal syndrome, thereby stimulating the development of the global market for the treatment of Hepatorenal syndrome.

Key players within global Hepatorenal Syndrome Treatment market include Cumberland Pharmaceuticals, Inc., Orphan Therapeutics, LLC., BioVie Inc. and Mallinckrodt Pharmaceuticals amongst others.

The report segments global Hepatorenal Syndrome Treatment market as follows:

Global Hepatorenal Syndrome Treatment Market: Treatment Segment Analysis
  • Therapeutics

  • Terlivaz
  • Glypressin
  • Lucassin
  • Hepatoren
  • Surgical Treatment

  • Liver Transplantation
  • Surgical Shunting
  • Renal Replacement Therapy
  • Others
Global Hepatorenal Syndrome Treatment Market: End users Segment Analysis
  • Hospitals and Clinics
  • Ambulatory Surgical centers
  • Academic Research Institutes
  • Others

Global Hepatorenal Syndrome Treatment Market: Type Segment Analysis
  • Type 1 Hepatorenal Syndrome
  • Type 2 Hepatorenal Syndrome

Global Hepatorenal Syndrome Treatment Market: Regional Segment Analysis
  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa

Table of Contents

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology


  • Chapter 2. Executive Summary
    • 2.1. Hepatorenal Syndrome Treatment Market, 2016 - 2025, (USD Billion)
    • 2.2. Hepatorenal Syndrome Treatment Market: Snapshot

  • Chapter 3. Global Hepatorenal Syndrome Treatment Market - Industry Analysis
    • 3.1. Hepatorenal Syndrome Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Technological advancements

    • 3.3. Restraints
      • 3.3.1. Fewer side effects of the treatment

    • 3.4. Opportunity
      • 3.4.1. Exploring new hepatorenal syndrome treatments

    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Treatment Segment
      • 3.6.2. Market attractiveness analysis by End users Segment
      • 3.6.3. Market attractiveness analysis by Type Segment
      • 3.6.4. Market attractiveness analysis by regional segment


  • Chapter 4. Global Hepatorenal Syndrome Treatment Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Hepatorenal Syndrome Treatment market: company market share analysis, 2018

    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion


  • Chapter 5. Global Hepatorenal Syndrome Treatment Market - Treatment Segment Analysis
    • 5.1. Global Hepatorenal Syndrome Treatment market overview: by Treatment
      • 5.1.1. Global Hepatorenal Syndrome Treatment market revenue share, by Treatment, 2018 and 2025

    • 5.2. Therapeutics
      • 5.2.1. Global Hepatorenal Syndrome Treatment market by Therapeutics, 2016-2025 (USD Billion)

    • 5.3. Surgical Treatment
      • 5.3.1. Global Hepatorenal Syndrome Treatment market by Surgical Treatment, 2016-2025 (USD Billion)


  • Chapter 6. Global Hepatorenal Syndrome Treatment Market - End users Segment Analysis
    • 6.1. Global Hepatorenal Syndrome Treatment market overview: by End users
      • 6.1.1. Global Hepatorenal Syndrome Treatment market revenue share, by End users, 2018 and 2025

    • 6.2. Hospitals and Clinics
      • 6.2.1. Global Hepatorenal Syndrome Treatment market by Hospitals and Clinics, 2016-2025 (USD Billion)

    • 6.3. Ambulatory Surgical centers
      • 6.3.1. Global Hepatorenal Syndrome Treatment market by Ambulatory Surgical centers, 2016-2025 (USD Billion)

    • 6.4. Academic Research Institutes
      • 6.4.1. Global Hepatorenal Syndrome Treatment market by Academic Research Institutes, 2016-2025 (USD Billion)


  • Chapter 7. Global Hepatorenal Syndrome Treatment Market - Type Segment Analysis
    • 7.1. Global Hepatorenal Syndrome Treatment market overview: by Type
      • 7.1.1. Global Hepatorenal Syndrome Treatment market revenue share, by Type, 2018 and 2025

    • 7.2. Type 1 Hepatorenal Syndrome
      • 7.2.1. Global Hepatorenal Syndrome Treatment market by Type 1 Hepatorenal Syndrome, 2016-2025 (USD Billion)

    • 7.3. Type 2 Hepatorenal Syndrome
      • 7.3.1. Global Hepatorenal Syndrome Treatment market by Type 2 Hepatorenal Syndrome, 2016-2025 (USD Billion)


  • Chapter 1. Global Hepatorenal Syndrome Treatment Market - Regional Analysis
    • 1.1. Global Hepatorenal Syndrome Treatment market overview: by region
      • 1.1.1. Global Hepatorenal Syndrome Treatment market revenue share, by region, 2018 and 2025

    • 1.2. North America
      • 1.2.1. North America Hepatorenal Syndrome Treatment market, by country, 2016-2025 (USD Billion)
      • 1.2.2. North America Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
      • 1.2.3. North America Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
      • 1.2.4. North America Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)
      • 1.2.5. The U.S.
        • 1.2.5.1. The U.S. Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.2.5.2. U.S. Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.2.5.3. U.S. Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.2.6. Rest of North America
        • 1.2.6.1. Rest of North America Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.2.6.2. Rest of North America Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.2.6.3. Rest of North America Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)


    • 1.3. Europe
      • 1.3.1. Europe Hepatorenal Syndrome Treatment market, by country, 2016-2025 (USD Billion)
      • 1.3.2. Europe Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
      • 1.3.3. Europe Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
      • 1.3.4. Europe Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)
      • 1.3.5. UK
        • 1.3.5.1. UK Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.3.5.2. UK Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.3.5.3. UK Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.3.6. France
        • 1.3.6.1. France Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.3.6.2. France Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.3.6.3. France Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.3.7. Germany
        • 1.3.7.1. Germany Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.3.7.2. Germany Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.3.7.3. Germany Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.3.8. Rest of Europe
        • 1.3.8.1. Rest of Europe Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.3.8.2. Rest of Europe Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.3.8.3. Rest of Europe Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)


    • 1.4. Asia Pacific
      • 1.4.1. Asia Pacific Hepatorenal Syndrome Treatment market, by country, 2016-2025 (USD Billion)
      • 1.4.2. Asia Pacific Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
      • 1.4.3. Asia Pacific Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
      • 1.4.4. Asia Pacific Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)
      • 1.4.5. China
        • 1.4.5.1. China Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.4.5.2. China Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.4.5.3. China Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.4.6. France
        • 1.4.6.1. Japan Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.4.6.2. Japan Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.4.6.3. Japan Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.4.7. India
        • 1.4.7.1. India Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.4.7.2. India Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.4.7.3. India Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.4.8. Rest of Asia Pacific
        • 1.4.8.1. Rest of Asia Pacific Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.4.8.2. Rest of Asia Pacific Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.4.8.3. Rest of Asia Pacific Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)


    • 1.5. Latin America
      • 1.5.1. Latin America Hepatorenal Syndrome Treatment market, by country, 2016-2025 (USD Billion)
      • 1.5.2. Latin America Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
      • 1.5.3. Latin America Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
      • 1.5.4. Latin America Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)
      • 1.5.5. Brazil
        • 1.5.5.1. Brazil Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.5.5.2. Brazil Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.5.5.3. Brazil Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)

      • 1.5.6. Rest of Latin America
        • 1.5.6.1. Rest of Latin America Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
        • 1.5.6.2. Rest of Latin America Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
        • 1.5.6.3. Rest of Latin America Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)


    • 1.6. Middle East & Africa
      • 1.6.1. Middle East and Africa Hepatorenal Syndrome Treatment market, by country, 2016-2025 (USD Billion)
      • 1.6.2. Middle East and Africa Hepatorenal Syndrome Treatment market revenue, by Treatment, 2016-2025 (USD Billion)
      • 1.6.3. Middle East and Africa Hepatorenal Syndrome Treatment market revenue, by End users, 2016-2025 (USD Billion)
      • 1.6.4. Middle East and Africa Hepatorenal Syndrome Treatment market revenue, by Type, 2016-2025 (USD Billion)


  • Chapter 2. Company Profiles
    • 2.1. Cumberland Pharmaceuticals, Inc.
      • 2.1.1. Overview
      • 2.1.2. Financials
      • 2.1.3. Product Portfolio
      • 2.1.4. Business Strategy
      • 2.1.5. Recent Developments

    • 2.2. Orphan Therapeutics, LLC.
      • 2.2.1. Overview
      • 2.2.2. Financials
      • 2.2.3. Product Portfolio
      • 2.2.4. Business Strategy
      • 2.2.5. Recent Developments

    • 2.3. BioVie Inc.
      • 2.3.1. Overview
      • 2.3.2. Financials
      • 2.3.3. Product Portfolio
      • 2.3.4. Business Strategy
      • 2.3.5. Recent Developments

    • 2.4. Mallinckrodt Pharmaceuticals
      • 2.4.1. Overview
      • 2.4.2. Financials
      • 2.4.3. Product Portfolio
      • 2.4.4. Business Strategy
      • 2.4.5. Recent Developments


Related Topics

Related Reports

Hepatorenal Syndrome Treatment Market Research Report by Type (Type 1 Hepatorenal Syndrome and Type 2 Hepatorenal Syndrome), Treatment, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030 - Product Image

Hepatorenal Syndrome Treatment Market Research Report by Type (Type 1 Hepatorenal Syndrome and Type 2 Hepatorenal Syndrome), Treatment, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • Report
  • 220 Pages
  • Global
From
Hepatorenal Syndrome Treatment Market Size Outlook to 2028 - Growth Opportunities, Hepatorenal Syndrome Treatment Market Insights, Companies, Market share by Types, Applications, and Countries - Product Image

Hepatorenal Syndrome Treatment Market Size Outlook to 2028 - Growth Opportunities, Hepatorenal Syndrome Treatment Market Insights, Companies, Market share by Types, Applications, and Countries

  • Report
  • 148 Pages
  • Global
From
Hepatorenal Syndrome Treatment Market Research Report by Type, Treatment, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030 - Product Image

Hepatorenal Syndrome Treatment Market Research Report by Type, Treatment, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • Report
  • 125 Pages
  • United States
From
Nephrology. A Comprehensive Guide to Renal Medicine. Edition No. 1. Lecture Notes - Product Image

Nephrology. A Comprehensive Guide to Renal Medicine. Edition No. 1. Lecture Notes

  • Book
  • 342 Pages
Sleisenger and Fordtran's Gastrointestinal and Liver Disease Review and Assessment. Edition No. 11 - Product Image

Sleisenger and Fordtran's Gastrointestinal and Liver Disease Review and Assessment. Edition No. 11

  • Book
Copyright © 2002-2023 Research and Markets. All Rights Reserved.